Article Details

Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet ...

Retrieved on: 2025-04-15 19:26:39

Tags for this article:

Click the tags to see associated articles and topics

Merck Signs Nearly $500 Million Licensing Deal With Austria-Based Cyprumed For Tablet .... View article details on hiswai:

Excerpt

... peptides, including GLP-1 analogs, macrocycles, and mini-proteins. ... What potential does oral peptide delivery hold for biotech firms? Could ...

Article found on: www.benzinga.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo